- Market Briefing
- Posts
- High-stakes
High-stakes
Trump seeks trade deal with Xi in high-stakes meeting, CPI set to quench data-starved investors' thirst, Trump pardons convicted Binance founder ‘CZ’, gold set to snap nine-week winning streak, and Intel rallies after forecast signals a comeback is underway...
Market Briefing
October 24, 2025
In partnership with
Good morning.
The Fast Five → Trump seeks trade deal with Xi in high-stakes meeting, CPI set to quench data-starved investors' thirst, Trump pardons convicted Binance founder ‘CZ’, gold set to snap nine-week winning streak, and Intel rallies after forecast signals a comeback is underway…
📌 Whenever the FDA approves a new drug... Timely investors could see 300-400% returns... ChemoCentryx soared 281% the year after it won FDA approval... Immunogen jumped 449% in the two years after it won FDA approval... Even Krystal Biotech rose 242% when it looked like it would win FDA approval, which it did. Here's the next stock we think has a good chance of winning FDA approval >>> (ad)
Calendar: (*Shutdown may affect key data. All times ET) - Full Calendar »
|
|
Your 5-minute briefing for Friday, Oct 24:
BEFORE THE OPEN
As of market close 10/23/2025.
Pre-Market:
 |  |
US Investor % Bullish Sentiment:
↓ 33.66% for Week of OCT 16 2025
Previous week: 45.87%
Market Wrap:
Futures flat ahead of CPI; Dow -18 (-0.04%), S&P +0.06%, Nasdaq +0.2%.
Intel +7% on strong Q3 sales; Target to cut 8% of corporate staff.
Applied Materials, Rivian also announce layoffs.
Thurs: S&P +0.6%, Dow +144, Nasdaq +0.9% led by AI names.
Today: CPI looms large amid data blackout from gov’t shutdown.
Markets expect Fed to cut rates again next week.
Stocks tracking weekly gains: S&P +1.1%, Nasdaq +1.2%, Dow +1.2%.
EARNINGS
FDA Approval Could Send this Stock Soaring
Whenever the FDA approves a new drug...
Timely investors could see 300-400% returns...
ChemoCentryx soared 281% in the year after it won FDA approval...
Immunogen jumped 449% in the two years after it won FDA approval...
Even Krystal Biotech rose 242% when it looked like it would win FDA approval, which it did.
- a message from Behind The Markets -
HEADLINES
President Trump is aiming for a quick win in a pivotal Thursday meeting with Chinese counterpart Xi Jinping, even if the outcome falls short of the sweeping deal he’s teased on issues at the heart of the rivalry between the world’s two largest economies.
The report, set for release today at 8:30 am ET, was delayed by the ongoing government shutdown. It marks the first major piece of federal economic data since the shutdown began.
Dow, S&P, Nasdaq futures hold steady as CPI inflation report looms (more)
Trump pardons convicted Binance founder Changpeng "CZ" Zhao (more)
Trump says all trade talks with Canada are terminated (more)
Trump cancels SF crackdown after Benioff, Huang Calls (more)
US weighs quantum computing boost in effort to counter China (more)
China deepens push for tech self-reliance ahead of US talks (more)
Dollar calm as traders gird for US inflation data (more)
Gold set to snap nine-week winning streak as US inflation test looms (more)
Asia shares gain on US-China trade hopes; oil eases (more)
Record $38B debt sale nears for Oracle-tied data centers (more)
Intel rallies after forecast signals a comeback is underway (more)
Apple begins shipping AI servers from Houston factory (more)
Target cuts 1800 corporate jobs in its first major layoffs in a decade (more)
Wall Street bonuses poised for record as bank profits surge (more)
California billionaires face a proposed 5% tax on wealth (more)
DEALFLOW
M+A | Investments
Goldman Sachs nears $1 billion deal for majority stake in Excel Sports
Fireblocks acquires Dynamic
Venus Aerospace receives strategic investment from Lockheed Martin
VC
Roller, a venue management platform for leisure and attractions venues, secured add’l $50M in funding
Clerq, a payments platform for high-ticket transactions, raised $21M in funding
Generation Lab, a company focused on longevity science, closed $11M in Seed funding
Wolf Games, a generative entertainment company, closed a $9M Series A funding round
OneAM, an early pay solution provider, raised a $4.7M Seed funding round
Moberg Analytics, a brain monitoring and critical-care informatics startup, raised $600K in Seed funding
The Smartest Free Crypto Event You’ll Join This Year
Curious about crypto but still feeling stuck scrolling endless threads? People who get in early aren’t just lucky—they understand the why, when, and how of crypto.
Join our free 3‑day virtual summit and meet the crypto experts who can help you build out your portfolio. You’ll walk away with smart, actionable insights from analysts, developers, and seasoned crypto investors who’ve created fortunes using smart strategies and deep research.
No hype. No FOMO. Just the clear steps you need to move from intrigued to informed about crypto.
CRYPTO
BULLISH BITES
🧸 Tariffs quietly reshaping how holiday toys reach stores.
🏀 Hamptons poker and mob meetings: NBA players accused in gambling scandal.
🛻 Spit On, Sworn At, and Undeterred: What it’s like to own a Cybertruck.
🚘 Meet the new $3 million Rolls-Royce Phantom Centenary.
DAILY SHARES
What stocks are Barron in?
“Quantum Computing, Sir.”
PUMP IT.
— Not Jerome Powell (@alifarhat79)
5:46 AM • Oct 23, 2025
Trump checking in on Barron after he told him to YOLO $INTC calls for earnings
— TrendSpider (@TrendSpider)
8:25 PM • Oct 23, 2025
“You invested into a fund that buys stakes in secondaries funds that buy stakes in private equity funds that buy stakes in companies?”
— litquidity (@litcapital)
3:20 AM • Oct 23, 2025
What did you think of today's Briefing? |
Have a comment or suggestion?
💌 Send us a message
*sponsored message
Disclaimer: Market Briefing© is a news publisher. All statements and expressions herein are the sole opinions of the authors or paid advertisers. The information, tools, and material presented are provided for informational purposes only, are not financial advice, and are not to be used or considered as an offer to buy or sell securities; and the publisher does not guarantee their accuracy or reliability. Please conduct your own research and consult an independent financial adviser before making any investments. Neither the publisher nor any of its affiliates accepts any liability whatsoever for any direct or consequential loss howsoever arising, directly or indirectly, from any use of the information contained herein. Assets mentioned may be owned by members of the Market Briefing team.
Reply